vTv Therapeutics, Inc. (VTVT)
30.58
+0.12
(+0.38%)
USD |
NASDAQ |
Sep 16, 16:00
30.58
0.00 (0.00%)
After-Hours: 20:00
vTv Therapeutics Price : 30.58 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 31.30 | 31.90 | 29.76 | 30.46 | 45336.00 |
| Sep 14, 2026 | 31.80 | 32.53 | 31.44 | 31.44 | 22152.00 |
| Sep 11, 2026 | 32.24 | 32.54 | 31.29 | 31.97 | 13723.00 |
| Sep 10, 2026 | 33.00 | 33.00 | 31.85 | 31.86 | 46338.00 |
| Sep 09, 2026 | 32.99 | 34.14 | 32.78 | 33.29 | 39543.00 |
| Sep 08, 2026 | 33.35 | 33.38 | 32.48 | 32.79 | 28071.00 |
| Sep 04, 2026 | 32.97 | 33.72 | 32.97 | 33.35 | 12065.00 |
| Sep 03, 2026 | 33.96 | 33.96 | 32.88 | 33.47 | 20869.00 |
| Sep 02, 2026 | 32.55 | 34.00 | 32.15 | 33.40 | 39757.00 |
| Sep 01, 2026 | 31.81 | 32.59 | 31.55 | 31.95 | 52700.00 |
| Aug 31, 2026 | 32.25 | 32.25 | 31.35 | 32.00 | 94153.00 |
| Aug 28, 2026 | 32.79 | 33.00 | 31.80 | 32.36 | 90241.00 |
| Aug 27, 2026 | 33.06 | 34.09 | 32.56 | 32.80 | 58434.00 |
| Aug 26, 2026 | 33.55 | 34.76 | 32.90 | 33.57 | 117244.0 |
| Aug 25, 2026 | 33.80 | 34.55 | 33.45 | 33.91 | 59297.00 |
| Aug 24, 2026 | 33.42 | 34.66 | 32.87 | 33.89 | 17998.00 |
| Aug 21, 2026 | 33.19 | 33.85 | 32.78 | 33.26 | 26674.00 |
| Aug 20, 2026 | 32.54 | 33.54 | 31.84 | 33.08 | 62706.00 |
| Aug 19, 2026 | 31.91 | 33.20 | 31.91 | 32.90 | 22564.00 |
| Aug 18, 2026 | 31.05 | 31.76 | 30.31 | 31.48 | 70289.00 |
| Aug 17, 2026 | 29.93 | 31.42 | 29.48 | 31.31 | 38771.00 |
| Aug 14, 2026 | 31.14 | 31.14 | 28.76 | 30.12 | 74834.00 |
| Aug 13, 2026 | 32.04 | 32.04 | 30.36 | 30.85 | 35453.00 |
| Aug 12, 2026 | 33.41 | 33.41 | 31.42 | 31.78 | 50545.00 |
| Aug 11, 2026 | 35.39 | 36.52 | 32.79 | 33.04 | 170844.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Spyre Therapeutics, Inc. | 91.22 |
| ACADIA Pharmaceuticals, Inc. | 27.52 |
| Alnylam Pharmaceuticals, Inc. | 239.50 |
| Anika Therapeutics, Inc. | 20.86 |
| Savara, Inc. | 5.14 |
Price Related Metrics
| PS Ratio | 9.858 |
| Price to Book Value | 1.532 |
| Earnings Yield | -3.46% |
| Market Cap | 120.43M |